FiscalNote (NOTE) Q4 2025 earnings review
Shrinking to Profitability: Huge Cuts Mask Core Business Decline
FiscalNote delivered Q4 revenue in line with guidance and beat on Adjusted EBITDA, but the underlying narrative is one of severe organic contraction. Unable to revive its top line—Pro Forma ARR fell another 9% year-over-year—management announced a massive 25% workforce reduction to force the company toward free cash flow positivity by early 2027. While legacy migrations are complete, macroeconomic headwinds and federal sector instability continue to weigh on renewals. The company is now pivoting hard into adjacent markets like Agentic AI APIs and Political Prediction Markets to expand its TAM, all while the Board continues its strategic review.
🐂 Bull Case
The company continues to expand margins despite revenue declines. The newly announced 25% workforce reduction structuralizes lower cash operating expenses, paving a clear, albeit delayed, path to positive TTM Free Cash Flow by Q1 2027.
Expanding the PolicyNote API with native Model Context Protocol (MCP) support to embed data directly into enterprise AI agents opens a highly scalable, non-seat-based monetization pathway.
🐻 Bear Case
Management predicted a return to ARR growth in H2 2025 in prior quarters. Instead, Q4 Pro Forma ARR declined by $0.7M sequentially and $8.0M year-over-year. The core business is still leaking revenue.
Through aggressive divestitures and churn, FiscalNote is now a significantly smaller business. FY26 revenue guidance of $80-$83M is a steep drop from the $120M printed in FY24, raising questions about long-term operating leverage.
⚖️ Verdict: 🔴
Bearish. Management is executing well on the only lever they fully control—costs. However, an organic ARR decline, a $12.4M goodwill impairment, and the failure to hit prior growth resumption targets indicate the core product is struggling in the market.
Key Themes
Failed Rebound: Pro Forma ARR Continues to Bleed
A critical red flag: throughout H1 2025, management explicitly guided to a return to ARR growth in the second half of the year. This failed to materialize. Q4 ending ARR was $84.1M, representing a $0.7M sequential decline from Q3 ($84.8M) and a 9% year-over-year drop on a pro forma basis. The company blamed cancellations among large enterprise customers and macro budget constraints, proving that the migration to the new PolicyNote platform has not yet solved net retention issues.
Aggressive Reorganization: 25% Workforce Reduction
Faced with stagnant top-line growth, management pulled the emergency brake on operating expenses. The company announced a 25% workforce reduction, heavily leveraging AI automation and offshoring. This move is expected to reduce cash costs by over 19% and structurally shift the company toward producing positive Free Cash Flow by Q1 2027.
Enterprise Quality Improving Despite Churn
While total volume is down, the quality of incoming revenue is improving. New corporate logo bookings increased 39% year-over-year in Q4. Crucially, the share of multi-year contracts among private sector customers surged from 17% to 40% year-over-year, locking in future stability and setting up a stronger foundation for gross retention in 2026 and beyond.
Goodwill Impairment Signals Diminished Asset Value
FiscalNote recorded a massive $12.4M goodwill impairment charge in Q4. This non-cash charge significantly widened the Net Loss to $(22.9)M from $(13.4)M a year ago. Following multiple divestitures (TimeBase, Aicel, Oxford Analytica), this impairment suggests that the carrying value of the remaining acquired legacy assets was fundamentally misaligned with their actual cash-generating power.
Other KPIs
Increased 16% YoY on a GAAP basis, completely reversing the cost-cut narrative at first glance. However, this was entirely driven by the $12.4M goodwill impairment. Excluding non-cash charges, amortization, and severance, Q4 operating expenses actually declined by $2.6M (12%) year-over-year.
A severe reversal from FY24's Net Income of $9.5M. The prior year was heavily artificially inflated by a $72M gain on the sale of businesses, whereas FY25 bore the brunt of heavy debt extinguishment costs ($8.0M), high interest expense ($16.5M), and the Q4 goodwill impairment ($12.4M).
Stable and incrementally accelerating. Up 100 bps from 87% in 24Q4. The divestiture of lower-margin advisory and service-heavy segments has left FiscalNote with a cleaner, highly profitable software margin profile, allowing more of every remaining dollar to fall to the bottom line.
Guidance
Decelerating. This compares to FY25 Pro Forma actuals of $90.7M. The guidance implies another ~10% year-over-year contraction in the business, underscoring that the top-line bleed will persist throughout the upcoming year despite new product launches.
Accelerating. An aggressive jump from the $9.0M generated in Pro Forma FY25. This 66% implied growth at the midpoint proves that the 25% headcount reduction will have an immediate and outsized impact on profitability, pushing implied Adjusted EBITDA margins toward 18.5%.
Decelerating sequentially. Down from Q4 2025's $22.2M and well below Q1 2025's Pro Forma actual of $23.1M. Management cited 'known, higher-than-normal seasonal cancellations in Q1' due to budget constraints and prior customer experiences on legacy systems.
Decelerating sequentially from Q4's $2.5M, reflecting the upfront transition costs and seasonal revenue dips before the full run-rate savings of the Q1 workforce reduction take effect in subsequent quarters.
Key Questions
ARR Growth Failure
Management explicitly guided to a return to ARR growth in H2 2025. Instead, Q4 ARR declined sequentially. What specifically broke down in the enterprise renewal motion, and why should investors trust the new baseline?
Workforce Reduction Impact on Sales
With a 25% reduction in workforce, how much of this cut impacts quota-carrying sales reps versus administrative staff? Are we sacrificing future pipeline generation to hit near-term EBITDA targets?
Prediction Markets Monetization
The entry into political prediction markets is a massive pivot from enterprise B2B SaaS. What is the specific monetization model for this segment, and how much capital is allocated to it in FY26?
Strategic Review Timeline
The Board's strategic review remains ongoing without a timeline. With the stock price depressed and further restructuring underway, what specific milestones is the Board evaluating before forcing a conclusion to this process?